EYLEA HD® (aflibercept) Injection 8 mg Approved by FDA for the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing Across Approved Indications

First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing ...
Food Safety News

More patients identified in outbreak of infant botulism tied to ByHeart formula

The patient count in an outbreak of infant botulism linked to ByHeart formula is continuing to increase, and federal ...

Cases jump to 31 in the botulism outbreak tied to baby formula. Here's what to know

More than 30 babies in 15 states have been sickened in a growing outbreak of infant botulism linked to recalled ByHeart ...
PharmExec

Winners & Losers: What the First FDA Commissioner’s National Priority Vouchers Tell Us About Early Movers vs. Late Movers

The first wave of Commissioner’s National Priority Vouchers signals a fundamental shift in FDA competitiveness, rewarding companies that pair breakthrough science with affordability commitments, ...

As infant botulism cases hits 31, recalled ByHeart baby formula still on store shelves

Health officials say at least 31 babies in 15 states have been treated for botulism as an outbreak tied to ByHeart formula ...

2 crooks pose as FDA officials to extort Rs 2.2k cr from Hetero, held

Hyderabad: Cyberabad cyber crime police Wednesday arrested two men for allegedly making a bid to extort a huge sum from ...

Meihua International Announces 1-For-100 Reverse Share Split

Meihua International Medical Technologies Co., Ltd. (“Meihua” or the “Company”) (Nasdaq: MHUA), reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating ...